The use of the type 2 diabetics medication metformin has been
The use of the type 2 diabetics medication metformin has been correlated with enhanced progression-free survival in ovarian cancer. in 5 (44%) of the 11 ovarian tumor major ethnicities, micromolar metformin improved the cytotoxic response to carboplatin but not really paclitaxel or doxorubicin. In summary, we present data that support the want for a medical … [Read more…]